SCHEDULE 13G/A: L1 Capital Divests Entire Stake in WORK Medical

L1 Capital Global Opportunities Master Fund, Ltd. has reported a complete divestment of its Class A Ordinary Shares in WORK Medical Technology Group LTD, reducing its beneficial ownership to 0%.

Summary

• L1 Capital Global Opportunities Master Fund, Ltd. filed an Amendment No. 1 to its Schedule 13G for WORK Medical Technology Group LTD.
• The filing indicates that L1 Capital now beneficially owns 0 Class A Ordinary Shares of WORK Medical Technology Group LTD.
• This represents 0.00% of the class of securities.
• Previously, L1 Capital had reported beneficial ownership of 7,897,548 Class A Ordinary Shares, which were purchased on September 26, 2025, and initially reported on October 3, 2025.
• The event requiring this filing occurred on November 14, 2025.

Sentiment

Score: 2

Explanation: The complete divestment by a significant institutional investor is a strong negative signal, indicating a loss of confidence or a strategic shift away from the issuer. This typically leads to downward pressure on the stock.

Negatives

• L1 Capital Global Opportunities Master Fund, Ltd. has fully divested its 7,897,548 Class A Ordinary Shares in WORK Medical Technology Group LTD.
• This reduces their beneficial ownership from a previously reported significant stake to 0.00%.

Future Outlook

NA

Management Comments

• David Feldman and Joel Arber, Directors of L1 Capital Global Opportunities Master Fund, Ltd., disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein.
• The inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 13 and the rules thereunder.

Industry Context

The complete divestment by an institutional investor like L1 Capital could signal a re-evaluation of WORK Medical Technology Group LTD's prospects or a shift in investment strategy within the broader medical technology sector. Such moves by significant funds are often watched by other market participants for potential implications on sector sentiment.

Stakeholder Impact

• Shareholders: Existing shareholders may experience decreased confidence and potential downward pressure on share price due to the institutional divestment.
• Potential Investors: May view the complete exit of a major fund as a red flag, impacting future investment decisions.

Key Dates

Recommendation

The complete divestment by L1 Capital Global Opportunities Master Fund, Ltd. of its entire stake in WORK Medical Technology Group LTD, reducing its ownership to 0%, is a significant negative indicator. Such a move by a sophisticated institutional investor often signals a loss of confidence in the company's future prospects or a fundamental change in its investment thesis. This action could trigger further selling pressure from other investors and warrants a 'sell' recommendation, or at least a re-evaluation of any existing 'hold' positions, until clearer positive catalysts emerge.

Keywords

WORK Medical Technology Group, L1 Capital, Schedule 13G, Institutional Ownership, Share Divestment, Class A Ordinary Shares, G9767H109